tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR

Voyager Therapeutics (VYGR) Income Statement

535 Followers

Voyager Therapeutics Income Statement

Last quarter (Q4 2023), Voyager Therapeutics's total revenue was $90.06M, a decrease of -5914.14% from the same quarter last year. In Q4, Voyager Therapeutics's net income was $56.40M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 250.01M$ 250.01M$ 40.91M$ 37.41M$ 171.13M$ 104.39M
Cost of Revenue
------
Gross Profit
$ 250.01M$ 250.01M$ 40.91M$ 37.41M--
Operating Expense
$ 127.99M$ 127.99M$ 91.74M$ -111.03M$ 143.74M$ 156.07M
Operating Income
$ 122.01M$ 122.01M$ -50.84M$ -73.62M$ 27.38M$ -51.68M
Net Non Operating Interest Income Expense
$ 11.72M$ 11.72M$ 1.79M$ -390.00K$ 1.66M$ 6.46M
Other Income Expense
$ -3.00K$ -3.00K$ -2.65M$ -2.81M$ 7.70M$ 1.63M
Pretax Income
$ 133.74M$ 133.74M$ -46.39M$ -71.20M$ 36.74M$ -43.60M
Tax Provision
$ 1.41M$ 1.41M$ 16.00K-$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 132.33M$ 132.33M$ -46.41M$ -71.20M$ 36.74M$ -43.60M
Basic EPS
$ 3.23$ 3.08$ -1.21$ -1.89$ 0.99$ -1.21
Diluted EPS
$ 3.00$ 2.97$ -1.21$ -1.89$ 0.98$ -1.21
Basic Average Shares
$ 172.08M$ 43.02M$ 38.36M$ 37.67M$ 37.13M$ 35.90M
Diluted Average Shares
$ 178.28M$ 44.57M$ 38.36M$ 37.67M$ 37.35M$ 35.90M
Dividend Per Share
---$ 0.00--
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 127.99M$ 127.99M$ 91.74M$ -111.03M$ 143.74M$ 156.07M
Net Income From Continuing And Discontinued Operation
$ 132.33M$ 132.33M$ -46.41M$ -71.20M$ 36.74M$ -43.60M
Normalized Income
$ 18.95M$ 105.65M$ -39.12M-$ 36.74M$ -43.60M
Interest Expense
------
EBIT
$ 131.87M$ 133.74M$ -46.39M$ -70.81M$ 27.38M$ -51.68M
EBITDA
$ 132.65M$ 134.51M$ -40.21M$ -65.26M$ 31.20M$ -48.91M
Currency in USD

Voyager Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis